By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoInk today announced an agreement with NanoGulf as its exclusive distributor in parts of the Middle East.

Territories covered by the deal include the United Arab Emirates, Qatar, Oman, Bahrain, and Saudi Arabia. The deal covers NanoInk's desktop nanofabrication equipment including the NLP 2000 System and the DPN 5000 System.

Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.